A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Dual Inhibitors Targeting DNA and Histone Deacetylases
2020
Pharmaceutical Fronts
Preserved Fulltext
AbstractHistone deacetylases (HDACs) regulate the acetylation status of histones and structural status of chromatin. The chromatin structure becomes relaxed after inhibition of HDAC, leading to DNA exposed to DNA disrupting agents, and eventually causing DNA dysfunction. Recently, more and more dual inhibitors targeting DNA and HDACs have been reported to be applied to cancer treatment. In this review, we describe the current status of dual inhibitors targeting DNA and HDACs, summarize their
doi:10.1055/s-0040-1713873
fatcat:xrgd5ghvendbdfb772gtxfkp6m